IDT CORP 8-K

What Happened IDT Corporation announced in an 8‑K filed June 11, 2026, that director Irwin Katsof resigned from the board and his committee assignments effective June 9, 2026. On the same date the board appointed William Conkling, age 55, to fill the vacancy. The board determined Mr. Conkling to be independent and expects him to serve as Audit Committee Chairman and the Audit Committee Financial Expert, and as a member of the Compensation and Corporate Governance Committees. Mr. Conkling’s term runs until the company’s 2026 annual meeting.

Key Details

• Resignation date: Irwin Katsof resigned effective June 9, 2026; resignation not due to any disagreement with the company.
• Appointment date & term: William Conkling appointed June 9, 2026; term expires at the 2026 annual meeting.
• Committee roles: Conkling expected to chair the Audit Committee and be designated the Audit Committee Financial Expert; also to join Compensation and Corporate Governance Committees.
• Background & independence: Conkling is Chief Commercial Officer at Protara Therapeutics (since June 2025), former CEO of Rafael Holdings (Feb 2022–May 2025), with prior senior commercial roles at Immunomedics and Novartis; board member of multiple healthcare companies; board determined him independent.
• Compensation: Conkling is eligible for the company’s Non‑Employee Director Compensation Program.
• No related-party issues: Company reported no family relationships or required Item 404(a) related-party transactions involving Conkling.

Why It Matters A board change can affect oversight, especially since Conkling is expected to lead the Audit Committee and serve as the Audit Committee Financial Expert — roles key to financial oversight and reporting quality. His commercial and life‑sciences experience may influence board-level strategic perspectives. The filing contains no indication of disagreement or governance concerns tied to the resignation, and Conkling’s independence was affirmed, which is relevant for investors monitoring board composition and governance practices.